Related MeSH Hierarchy (6)
Diseases [C] » Stomatognathic Diseases [C07] » Pharyngeal Diseases » Nasopharyngeal Diseases » Nasopharyngeal Neoplasms
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Head and Neck Neoplasms » Otorhinolaryngologic Neoplasms » Pharyngeal Neoplasms » Nasopharyngeal Neoplasms
Diseases [C] » Otorhinolaryngologic Diseases [C09] » Pharyngeal Diseases » Nasopharyngeal Diseases » Nasopharyngeal Neoplasms
Diseases [C] » Otorhinolaryngologic Diseases [C09] » Pharyngeal Diseases » Pharyngeal Neoplasms » Nasopharyngeal Neoplasms
Diseases [C] » Stomatognathic Diseases [C07] » Pharyngeal Diseases » Pharyngeal Neoplasms » Nasopharyngeal Neoplasms
Diseases [C] » Otorhinolaryngologic Diseases [C09] » Otorhinolaryngologic Neoplasms » Pharyngeal Neoplasms » Nasopharyngeal Neoplasms
Description
Tumors or cancer of the NASOPHARYNX. MeSH
Hierarchy View
Subtype Terms (1)
Nasopharyngeal Carcinoma
172 drugs (73 approved, 99 experimental)
Approved Indicated Drugs (1)
Phase 3 Indicated Drugs (16)
Phase 2 Indicated Drugs (33)
Phase 1 Indicated Drugs (18)
Other Experimental Indicated Drugs (5)
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 2 Indications (54)
China International Medical Foundation
Chinese Academy of Medical Sciences
Dalian Merro Pharmaceutical Co. Ltd
European Organisation for Research and Treatment of Cancer
First People's Hospital of Foshan
National Cancer Institute (NCI)
National University of Singapore
Radiation Therapy Oncology Group
Shenzhen Hank Bioengineering Institute
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (5)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
